InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

- Current share price for OCC : $0.690

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$188 Appendix 3B 20 Jun 2017 8:24AM $0.350 $0.690 risen by 97.14%
$188 Ortho-ACI on Australian Register of Therapeutic Goods 30 May 2017 9:12AM $0.370 $0.690 risen by 86.49%
$188 Ethics Approval Received for Pilot Ortho-ATI Tendon Study 1 May 2017 9:09AM $0.415 $0.690 risen by 66.27%
$188 Appendix 4C - quarterly 28 Apr 2017 6:52PM $0.415 $0.690 risen by 66.27%
$188 Response to ASX Query 11 Apr 2017 9:35AM $0.495 $0.690 risen by 39.39%
$188 Response to ASX Price and Volume Query 10 Apr 2017 4:44PM $0.440 $0.690 risen by 56.82%
$188 Singapore Patent for CelGro SMART Graft Received 28 Mar 2017 8:27AM $0.395 $0.690 risen by 74.68%
$188 Appendix 3B 22 Mar 2017 8:06PM $0.415 $0.690 risen by 66.27%
$188 Half Yearly Report and Accounts 28 Feb 2017 2:54PM $0.435 $0.690 risen by 58.62%
$188 Orthocell Announces Gluteal Tendon Publication 27 Feb 2017 9:36AM $0.445 $0.690 risen by 55.06%
$188 Investor Presentation Hong Kong 27 Feb 2017 9:30AM $0.445 $0.690 risen by 55.06%
$188 Initial Results Positive for CelGro Human Nerve Regeneration 22 Feb 2017 9:21AM $0.450 $0.690 risen by 53.33%
$188 Orthocell Submits US Regulatory Application for CelGro 8 Feb 2017 9:56AM $0.460 $0.690 risen by 50%
$188 Orthocell Submits US Regulatory Application for CelGro 8 Feb 2017 9:33AM $0.460 $0.690 risen by 50%
$188 Appendix 4C - quarterly 31 Jan 2017 5:37PM $0.445 $0.690 risen by 55.06%
$188 Orthocell Cell Factory Patent Granted in Europe 31 Jan 2017 9:52AM $0.435 $0.690 risen by 58.62%
$188 Orthocell Announces Collaboration with Johnson & Johnson 12 Jan 2017 9:58AM $0.465 $0.690 risen by 48.39%
$188 Trading Halt 11 Jan 2017 9:53AM $0.440 $0.690 risen by 56.82%
$188 Orthocell receives R&D tax incentive refund 9 Jan 2017 3:48PM $0.425 $0.690 risen by 62.35%
$188 Ceasing to be a substantial holder 16 Dec 2016 10:31AM $0.430 $0.690 risen by 60.47%
$188 Ceasing to be a substantial holder 15 Dec 2016 4:24PM $0.430 $0.690 risen by 60.47%
$188 Placement Completed 13 Dec 2016 11:26AM $0.435 $0.690 risen by 58.62%
$188 Appendix 3B 13 Dec 2016 11:22AM $0.435 $0.690 risen by 58.62%
$188 Change of Share Registry Address 9 Dec 2016 1:36PM $0.440 $0.690 risen by 56.82%
$188 Orthocell Announces $4 million Capital Raising 7 Dec 2016 10:02AM $0.455 $0.690 risen by 51.65%

651 - 675 of 771 results

Page 27 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.